Clinical Trial of Sacral Neuromodulation for Treatment of Refractory Overactive Bladder (OAB)

Status

UNKNOWN

Phases

Early Phase 1

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT02619721

Enrollment

Registered

2015-12-02

Start date

2015-10-31

Completion date

2018-02-28

Last updated

2016-10-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Refractory Overactive Bladder

Keywords

PINS SNS OAB

Brief summary

Evaluate the long-term clinical effectiveness and safety of the PINS Sacral Neuromodulation to patients with refractory Overactive Bladder.

Interventions

DEVICEPINS SNS

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

TREATMENT

Masking

SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender

ALL

Age

16 Years to No maximum

Healthy volunteers

Inclusion criteria

* Age greater than 16 years OAB and/or OAB symptoms Refractory to standard medical therapy 100ml bladder capacity with normal upper urinary tract Good surgical candidate Able to complete study documentation and return for followup evaluation

Exclusion criteria

* Neurological conditions Stress urinary incontinence OAB symptoms caused by urinary tract infections

Design outcomes

Primary

Measure	Time frame
Changes in voiding frequency from baseline to the voiding frequency evaluvation period 6 month	6 month of stimulation

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026